GLP1R and atherosclerosis: Interestingly, Song et al. in a meta-analysis published in 2015 provided preliminary evidence in favor of GLP-1-based therapies in overcoming atherosclerosis development/progression, which is also substantiated by the significant decreases in the total cholesterol, LDL cholesterol and triglycerides [98].